Bon Natural Life Ltd. (Nasdaq: BON), a leading bio-ingredient solution provider in the natural, health, and personal care industry based in Xi'an, China, has announced that it has regained compliance with Nasdaq's continued listing requirements. The company received official confirmation from the Nasdaq Hearings Panel on July 2, 2025, indicating that it successfully met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2). Consequently, BON's request to maintain its listing on the Nasdaq Capital Market has been approved. The company had submitted a compliance plan on May 16, 2025, and presented its case on June 5, 2025. BON will remain under a Discretionary Panel Monitor for one year to ensure ongoing compliance with Nasdaq's listing standards.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.